Equities research analysts at Raymond James assumed coverage on shares of Jazz Pharmaceuticals (NASDAQ:JAZZ – Get Free Report) in a note issued to investors on Thursday, FlyOnTheWall reports. The brokerage set a “market perform” rating on the specialty pharmaceutical company’s stock. Other analysts have also recently issued reports about the company. Needham & Company LLC […]
Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Get Free Report) CAO Patricia Carr sold 158 shares of the firm’s stock in a transaction that occurred on Monday, August 14th. The shares were sold at an average price of $138.16, for a total value of $21,829.28. Following the completion of the sale, the chief accounting officer now owns […]
Jazz Pharmaceuticals (NASDAQ:JAZZ – Free Report) had its price objective raised by Bank of America from $204.00 to $217.00 in a research note published on Thursday morning, Marketbeat Ratings reports. The firm currently has a buy rating on the specialty pharmaceutical company’s stock. A number of other analysts also recently issued reports on JAZZ. StockNews.com […]
Jazz Pharmaceuticals (NASDAQ:JAZZ – Get Free Report) updated its FY 2023 earnings guidance on Thursday. The company provided EPS guidance of $18.15-$19.00 for the period, compared to the consensus EPS estimate of $17.48. The company issued revenue guidance of $3.73 billion-$3.88 billion, compared to the consensus revenue estimate of $3.78 billion. Analyst Ratings Changes A […]
Jazz Pharmaceuticals (NASDAQ:JAZZ) Issues FY23 Earnings Guidance modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.